GGrantIndex
Sort

48,018 grants matching immunotherapy

Targeted antigen receptor treatment of cancer

$2,174,795
Alan N. Houghton · Sloan-Kettering Inst Can Research · P01 · FY2006 · CA

Mechanisms of peripheral induction of T-cell tolerance

$2,173,652
Kristin A. Hogquist · University Of Minnesota · P01 · FY2019 · AI

University of Texas Southwestern Medical Center SPORE in Kidney Cancer

$2,173,410
James Brugarolas · Ut Southwestern Medical Center · P50 · FY2022 · CA

University of Texas Southwestern Medical Center SPORE in Kidney Cancer

$2,173,408
James Brugarolas · Ut Southwestern Medical Center · P50 · FY2023 · CA

SPORE in Brain Cancer

$2,171,252
Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2025 · CA

Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance

$2,171,238
Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2018 · CA

Center for Cancer Biology Research

$2,170,918
W Keith Miskimins · Sanford Research/Usd · P20 · FY2013 · GM

Experimental Therapy for Brain Tumors

$2,170,371
John H Sampson · Duke University · P01 · FY2018 · CA

PATHOGENESIS AND TREATMENT OF ACUTE HIV INFECTION

$2,170,255
Massachusetts General Hospital · U01 · FY2003 · AI

Synergies among inhibitory receptors in tolerance, cancer and antiviral immunity

$2,170,094
Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2017 · AI

Precision Medicine of Cancer

$2,168,979
Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

p53, Aging, and Cancer

$2,168,979
Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

University of Wisconsin Prostate SPORE

$2,167,946
David F Jarrard · University Of Wisconsin-Madison · P50 · FY2025 · CA

Multiscale Analysis of Immune Responses

$2,166,719
Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

HCC Ovarian Cancer SPORE

$2,165,016
Ronald J Buckanovich · University Of Pittsburgh At Pittsburgh · P50 · FY2024 · CA

Deciphering LKB1-associated immunotherapy resistance in lung adenocarcinoma (LUAD)

$2,164,833
Haian Fu · Emory University · P01 · FY2023 · CA

Molecular Diagnostics Core Laboratory

$2,164,058
Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA

The Biology of HIV Infections

$2,164,017
Malcolm Martin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

HCC Ovarian Cancer SPORE

$2,163,827
Ronald J Buckanovich · University Of Pittsburgh At Pittsburgh · P50 · FY2023 · CA

Lymphoma Specialized Program of Research Excellence

$2,163,693
University Of Iowa · P50 · FY2003 · CA

City of Hope Lymphoma SPORE

$2,163,323
Stephen J Forma · Beckman Research Institute/City Of Hope · P50 · FY2007 · CA

Tumor Microenvironment-TME CoBRE

$2,163,322
Paul R Lockman · West Virginia University · P20 · FY2025 · GM

City of Hope Lymphoma SPORE

$2,163,322
Stephen J Forma · Beckman Research Institute/City Of Hope · P50 · FY2008 · CA

Immunotherapy for Ocular Surface Diseases

$2,163,291
Sandeep Jain · University Of Illinois At Chicago · R24 · FY2021 · EY

City of Hope Lymphoma SPORE

$2,162,001
Stephen J Forma · Beckman Research Institute/City Of Hope · P50 · FY2014 · CA